Airmid Healthgroup’s Visit to Asia Coincides with MERS Outbreak: A Spotlight on Viral Testing Expertise

By Dr. Natasha Gordon, PhD, microbiology researcher at Airmid Healthgroup. Read more about her work here

Published: July 7, 2015

MERS-CoV warning sign at Seoul airport with masked staff member during 2015 outbreak showed how virus testing is so important
MERS CoV warning displayed in Seoul during Airmid Healthgroups visit amid the outbreak in 2015

During a recent visit to Asia, the Airmid Healthgroup team was in Seoul, South Korea at the same time the city was experiencing an outbreak of Middle East Respiratory Syndrome (MERS). Caused by the MERS coronavirus (MERS-CoV), this respiratory illness was first identified in Saudi Arabia in 2012 and has since drawn global attention due to its potential for rapid spread.

The presence of MERS in Seoul added to the region’s ongoing concerns about viral outbreaks. Asia has been significantly impacted by a series of high-profile virus epidemics in recent years, including:

  • Severe Acute Respiratory Syndrome (SARS) – 2002/2003
  • Hand, Foot and Mouth Disease (HFMD) – 2008/2009
  • Influenza A H1N1 (Swine Flu) – 2009

Supporting Manufacturers with Viral Testing and Certification

In response to increased public health concerns, many manufacturers are prioritizing solutions that can help reduce the risk of viral exposure in indoor environments. At Airmid Healthgroup, we partner with leading Asian and global companies to validate and certify their health-related product claims using rigorous scientific methods.

Our ISO 17025-accredited laboratory conducts virus testing on a wide range of consumer and commercial products, including:

We routinely work with viruses such as:

  • Influenza A (H1N1)
  • Human Rhinovirus 16 – a leading cause of the common cold
  • Human Coronavirus 229E – a close genetic relative to more severe coronaviruses

When direct testing with specific viruses is not feasible, we utilize genetically related viral surrogates for reliable, science-based outcomes. Our virus testing capabilities include:

  • Viral culture methods
  • ELISA (enzyme-linked immunosorbent assay)
  • qPCR (quantitative polymerase chain reaction)
  • Synthetic skin models to evaluate viral adherence to skin-like surfaces

These advanced analytical techniques are combined with biological particle modeling to simulate real-world exposure scenarios, offering manufacturers data-driven insights and a clear path to product differentiation and certification.

Learn More

If you are developing antiviral technologies or need support in validating health claims related to viral efficacy, Airmid Healthgroup can help.

Contact our team for expert guidance on customized testing programs designed to meet regulatory and market needs.

Reference:
Centers for Disease Control and Prevention (CDC) – About MERS

Related Testing Services

Bioaerosol Chamber Testing

Germicidal UV Testing (ASHRAE 185 Series)

– HVAC Filtration and Air Cleaner Performance Testing (ASHRAE 52.2)

Antimicrobial Surface Testing (ISO 22196 & ASTM E2149)

Related Case Studies

– APCO Air Purifier Validated by Airmid Healthgroup

Related Blog Posts

-Advancing the Science of UV Disinfection: Insights from the IUVA & NIST Workshop

ASHRAE Standard 241: Control of Infectious Aerosols – Understanding its Impact

An Overview of the ASHRAE 185 Series Standards for Evaluating Air Cleaning Technologies

The Role of Independent Testing in HVAC Filtration: Ensuring Air Quality Standards

Keywords

viral product testing, MERS outbreak, viral testing, product certification, antiviral testing, air purifier testing, humidifier testing, virus validation, Airmid Healthgroup, indoor air quality, third-party lab

Do you want to validate your technology?

Contact the Airmid Healthgroup team today to learn more about the independent testing process and how it can enhance your product’s credibility in the market.

Click Here

author avatar
Natasha Gordon

Natasha Gordon PhD is Lead R&D Scientist at airmid healthgroup.

Scroll to Top